Operating Cash Flow
Revolution Medicines, Inc. Operating Cash Flow decreased by 29.1% to -$354.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 82.2%, from -$194.44M to -$354.17M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a 57.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$34.08M | -$36.59M | -$39.27M | -$55.16M | -$55.72M | -$51.74M | -$61.79M | -$62.39M | -$67.12M | -$100.50M | -$120.56M | -$160.56M | -$128.17M | -$130.42M | -$138.29M | -$194.44M | -$221.76M | -$207.31M | -$274.24M | -$354.17M |
| QoQ Change | — | -7.4% | -7.3% | -40.5% | -1.0% | +7.1% | -19.4% | -1.0% | -7.6% | -49.7% | -20.0% | -33.2% | +20.2% | -1.8% | -6.0% | -40.6% | -14.1% | +6.5% | -32.3% | -29.1% |
| YoY Change | — | — | — | — | -63.5% | -41.4% | -57.4% | -13.1% | -20.5% | -94.2% | -95.1% | -157.3% | -90.9% | -29.8% | -14.7% | -21.1% | -73.0% | -59.0% | -98.3% | -82.2% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s operating cash flow?
- Revolution Medicines, Inc. (RVMD) reported operating cash flow of -$354.17M in Q1 2026.
- How has Revolution Medicines, Inc.'s operating cash flow changed year-over-year?
- Revolution Medicines, Inc.'s operating cash flow decreased by 82.2% year-over-year, from -$194.44M to -$354.17M.
- What is the long-term trend for Revolution Medicines, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s operating cash flow has grown at a 57.2% compound annual growth rate (CAGR), from -$147.18M to -$897.74M.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.